Annual Report and Consolidated Financial Statements

The report covers a transitional 15-month period ending 31 March 2026 and reports consolidated revenue of £4,852,265. It highlights regulatory approvals and new commercial partnerships for Mevalone, Novellus+, Ecovelex, and Cedroz. The report also introduces an ESG strategy supported by a CEO-owned plan, an ESG Steering Committee, and regular Board reporting.